Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study

Documenti analoghi

• GV‐971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities
  di: Xinying Yang, et al.
  Pubblicazione: (2024)
• The severity assessment of Parkinson's disease based on plasma inflammatory factors and third ventricle width by transcranial sonography
  di: Yue Lu, et al.
  Pubblicazione: (2024)
• Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol
  di: Liu Liu, et al.
  Pubblicazione: (2024)
• Increased opioid consumption in neoadjuvant immunotherapy plus chemotherapy for patients with non‐small‐cell lung cancer: A multicenter, prospective cohort study
  di: Kaiyuan Wang, et al.
  Pubblicazione: (2024)
• Identification and characterization of a novel intronic splicing mutation in CSF1R‐related leukoencephalopathy
  di: Yilai Han, et al.
  Pubblicazione: (2024)